BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34209278)

  • 1. NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells.
    Liu WJ; Huang YX; Wang W; Zhang Y; Liu BJ; Qiu JG; Jiang BH; Liu LZ
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JI017, a Complex Herbal Medication, Induces Apoptosis via the Nox4-PERK-CHOP Axis in Ovarian Cancer Cells.
    Kim T; Ko SG
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of NADPH Oxidase 4 Attenuates Hypoxia Resistance in Neuroblastoma Cells SH-SY5Y by Inhibiting PI3K/Akt-Dependent Glycolysis.
    Yu T; Li L; Liu W; Ya B; Cheng H; Xin Q
    Oncol Res; 2019 May; 27(5):525-532. PubMed ID: 29426376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.
    Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS
    PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro.
    Meng D; Mei A; Liu J; Kang X; Shi X; Qian R; Chen S
    PLoS One; 2012; 7(10):e48393. PubMed ID: 23144758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
    Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
    Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma.
    Su X; Yang Y; Yang Q; Pang B; Sun S; Wang Y; Qiao Q; Guo C; Liu H; Pang Q
    BMC Cancer; 2021 Nov; 21(1):1181. PubMed ID: 34740322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.
    Diebold I; Petry A; Hess J; Görlach A
    Mol Biol Cell; 2010 Jun; 21(12):2087-96. PubMed ID: 20427574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 Activation Induced by Sirt1 Ameliorates Acute Lung Injury After Intestinal Ischemia/Reperfusion Through NOX4-Mediated Gene Regulation.
    Chai D; Zhang L; Xi S; Cheng Y; Jiang H; Hu R
    Cell Physiol Biochem; 2018; 46(2):781-792. PubMed ID: 29621765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB.
    Rohwer N; Dame C; Haugstetter A; Wiedenmann B; Detjen K; Schmitt CA; Cramer T
    PLoS One; 2010 Aug; 5(8):e12038. PubMed ID: 20706634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding NADPH oxidase 4 expression in human tumors.
    Meitzler JL; Makhlouf HR; Antony S; Wu Y; Butcher D; Jiang G; Juhasz A; Lu J; Dahan I; Jansen-Dürr P; Pircher H; Shah AM; Roy K; Doroshow JH
    Redox Biol; 2017 Oct; 13():182-195. PubMed ID: 28578276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
    Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
    Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
    Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
    Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer.
    Camblin AJ; Tan G; Curley MD; Yannatos I; Iadevaia S; Rimkunas V; Mino-Kenudson M; Bloom T; Schoeberl B; Drummond DC; Lugovskoy AA; Louis CU; Askoxylakis V
    Sci Rep; 2019 Nov; 9(1):16832. PubMed ID: 31728045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model.
    Gao F; Chattopadhyay A; Navab M; Grijalva V; Su F; Fogelman AM; Reddy ST; Farias-Eisner R
    J Pharmacol Exp Ther; 2012 Aug; 342(2):255-62. PubMed ID: 22537771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression.
    Qin J; Liu Y; Lu Y; Liu M; Li M; Li J; Wu L
    Sci Rep; 2017 Sep; 7(1):10592. PubMed ID: 28878214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.